Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01587989
What this trial is testing

RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 77
Not applicableUnknownNCT05911880
What this trial is testing

The Effect of a Plant-based Diet on the Active Rheumatoid Arthritis Activity.

Who this might be right for
Rheumatoid ArthritisDiet, HealthyInflammatory Response
Instituto Nacional de Cardiologia Ignacio Chavez 28
Large-scale testing (Phase 3)Study completedNCT01519791
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 880
Early research (Phase 1)UnknownNCT00002396
What this trial is testing

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 60
Not applicableStudy completedNCT02509897
What this trial is testing

Normobaric Hypoxic Training and Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Charite University, Berlin, Germany 39
Not applicableStudy completedNCT02533882
What this trial is testing

Lakeshore Examination of Activity and Disability Exercise Response Study

Who this might be right for
Multiple SclerosisStroke
University of Alabama at Birmingham 180
Testing effectiveness (Phase 2)Study completedNCT00270205
What this trial is testing

Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Testing effectiveness (Phase 2)Study completedNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Not applicableWithdrawnNCT01771614
What this trial is testing

Glucotoxicity and Acute Exercise

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Rigshospitalet, Denmark
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Large-scale testing (Phase 3)Study completedNCT02746380
What this trial is testing

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Rheumatoid
LG Life Sciences 383
Testing effectiveness (Phase 2)Study completedNCT01430507
What this trial is testing

A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Glenmark Pharmaceuticals Ltd. India 406
Post-approval studies (Phase 4)Study completedNCT00234897
What this trial is testing

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abbott 1,938
Large-scale testing (Phase 3)UnknownNCT02357069
What this trial is testing

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Who this might be right for
Arthritis, Rheumatoid
LG Life Sciences 372
Large-scale testing (Phase 3)Study completedNCT02706951
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)

Who this might be right for
Rheumatoid Arthritis
AbbVie 648
Testing effectiveness (Phase 2)Study completedNCT05133297
What this trial is testing

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hangzhou Highlightll Pharmaceutical Co., Ltd 101
Not applicableStudy completedNCT00548990
What this trial is testing

The Immune Function Intervention Trial

Who this might be right for
Immune Response
National Institute on Aging (NIA) 150
Testing effectiveness (Phase 2)Study completedNCT03682705
What this trial is testing

Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 242
Large-scale testing (Phase 3)Study completedNCT00891046
What this trial is testing

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 270
Large-scale testing (Phase 3)Study completedNCT02151851
What this trial is testing

Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA, Belgium 430
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation